Core Insights - Smith + Nephew (SNN) has formed a strategic partnership with Standard Health to establish the UK's first dedicated Orthopaedic Ambulatory Surgery Centre (ASC) in Poole, Dorset, aimed at transforming outpatient orthopedic care [1][4][6] - The collaboration combines SNN's innovative surgical solutions with Standard Health's clinical expertise to enhance patient outcomes and reduce surgical wait times [2][4] - SNN's market capitalization stands at $12.52 billion, with projected fiscal 2025 revenues of $6.12 billion, indicating a growth of 10.3% from fiscal 2023 [5] Company Developments - The new ASC will focus on minimally invasive procedures, including rotator cuff repairs, ACL reconstructions, and joint replacements, catering to both NHS and private patients [1][7] - SNN is positioned to capitalize on the growing trend towards outpatient orthopedic procedures, enhancing its presence in the ASC market and driving adoption of its surgical technologies [4][9] - Standard Health plans to expand to 20 ASC sites across the UK by 2030, providing SNN with scalable opportunities to deepen its market presence [6][9] Industry Trends - The global ambulatory surgery centers market is projected to grow from $134.9 billion in 2023 to $205.5 billion by 2030, with a CAGR of 6.2% from 2024 to 2030, driven by a shift of surgical procedures from hospitals to ASCs [10] - The ASC model has shown greater procedural efficiency and patient satisfaction, making it an attractive alternative to traditional hospital settings [8][10] - With over 850,000 patients awaiting orthopedic surgeries in the UK, the NHS is increasingly relying on independent providers to alleviate backlogs, indicating a strong demand for SNN's services [9]

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wrist proced ...

Core Viewpoint - Smith+Nephew has announced a strategic partnership with Standard Health to develop the first Orthopaedic Ambulatory Surgery Centre in the UK, aimed at improving access to advanced joint repair and replacement technologies for both NHS and private patients [1][2]. Group 1: Partnership Details - The new centre will be located in Poole, Dorset, and is expected to open in 2025, serving thousands of patients annually, primarily through NHS referrals [3][4]. - Standard Health will manage the site development and operation, while Smith+Nephew will provide its innovative medical technologies [2][10]. - Standard Health plans to expand by opening an additional 10 sites in the UK over the next three years, totaling 20 by 2030 [2]. Group 2: Operational Model and Benefits - The centre will adopt the Ambulatory Surgery Center (ASC) model from the US, which has proven benefits such as greater procedural efficiency, a 92% patient satisfaction rate, and a 40% reduction in costs for outpatient joint replacements compared to hospital-based surgeries [3][6]. - The UK currently has over 850,000 individuals waiting for orthopaedic surgery, highlighting the need for independent providers to meet this demand [3]. Group 3: Strategic Goals - The partnership aims to redefine the UK independent care provider model for orthopaedics, ensuring a standard quality of care and long-term sustainability for NHS commissioners [4]. - The collaboration is positioned to address the significant waiting times for procedures in the UK, leveraging Smith+Nephew's expertise in ASCs to enhance patient outcomes [4][10].

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1 With the ability to be used with or without the Posterior Cruciate Ligament (PCL), procedural trends are moving away from Posterior Stabilized (PS) design types to more bone-conservative C ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA). The RENASYS TOUCH NPWT System demonstrated clinical efficacy,1,2,3,4 and operational fitness including portability,2 an intuitive interface,5,6,7 and the ability to provide a range of therapy modes, ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA). The RENASYS TOUCH NPWT System demonstrated clinical efficacy,1,2,3,4 and operational fitness including portability,2 an intuitive interface,5,6,7 and the ability to provide a range of therapy modes, ...

Professor Elizaveta Kon from Humanitas Research Hospital, who plans to present 4-year outcomes of the implant with respect to gender during AANA 2025, highlighted the importance of inclusivity in study design. "We need a technology that we can trust to work in the patients we see day-to-day. This is where CARTIHEAL has excelled, showcasing superior performance across genders, lesion location, and more." Dr. Vinod Dasa of Louisiana State University School of Medicine finds the technology particularly meaning ...

“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a months-long roadshow across central Europe to promote its CORI Surgical System – an advanced robotics-assisted surgical platform for total knee and hip joint replacement procedures. The tour will commence in Berlin today and make dozens of stops at surgical facilities across Germany, Austria and Switzer ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional val ...

Core Insights - Smith & Nephew plc is undergoing a transformation under the new leadership of CEO Deepak Nath, who was appointed in April 2022, aiming to address previous operational underperformance [1] Company Overview - The company is focusing on identifying high-quality investment opportunities and addressing mispricing in the market [1]